ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,279Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 890

$1.07M Total Retail Price of All Prescriptions

Rank: 43 out of 890

753 Patients Receiving at Least One Drug in Part D
74%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 753 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

24% of this provider’s 753 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 16,557 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
SIMVASTATIN 901 755 1 5
AMLODIPINE BESYLATE 677 549 2 1
HYDROCODONE-ACETAMINOPHEN 621 299 S3 3 3
LISINOPRIL 600 459 4 4
POTASSIUM CHLORIDE 576 460 5 11
LEVOTHYROXINE SODIUM 559 487 6 2
OMEPRAZOLE 551 429 7 8
DICLOFENAC SODIUM 448 329 8 96
FUROSEMIDE 403 310 9 7
ATENOLOL 375 257 10 23
GABAPENTIN 373 284 11 12
TORSEMIDE 354 291 12 159
GLIMEPIRIDE 342 249 13 27
METOPROLOL TARTRATE 337 258 14 15
WARFARIN SODIUM 310 238 15 24
METFORMIN HCL 305 229 16 6
DONEPEZIL HCL 300 300 17 30
METOPROLOL SUCCINATE 296 256 18 17
KLOR-CON M20 260 226 19 72
PRAVASTATIN SODIUM 253 199 20 10
TRAMADOL HCL 250 206 21 16
SERTRALINE HCL 247 160 22 26
NEXIUM 220 146 23 14
HYDROCHLOROTHIAZIDE 211 164 24 9
LOSARTAN POTASSIUM 211 183 24 29
NAMENDA 205 205 26 36
DIVALPROEX SODIUM 200 156 27 126
ALLOPURINOL 196 137 28 31
TRAZODONE HCL 186 128 29 40
PANTOPRAZOLE SODIUM 185 113 30 34
CARVEDILOL 180 132 31 22
ATORVASTATIN CALCIUM 171 132 32 13
MELOXICAM 157 119 33 18
LANTUS 153 104 34 50
ISOSORBIDE MONONITRATE ER 151 110 35 60
FLUOXETINE HCL 148 92 36 63
DIGOXIN 146 114 37 65
CLONIDINE HCL 146 96 37 35
AMITRIPTYLINE HCL 145 119 R 39 43
ALENDRONATE SODIUM 145 119 39 38
TAMSULOSIN HCL 140 120 41 32
ZOLPIDEM TARTRATE 138 92 42 19
CLOPIDOGREL 133 99 43 28
ENALAPRIL MALEATE 125 114 44 56
PAROXETINE HCL 124 80 45 68
LYRICA 123 41 46 71
HYDROXYZINE HCL 122 36 R 47 200
RISPERIDONE 121 80 48 78
DILTIAZEM 24HR CD 120 85 49 156
NAPROXEN 114 85 50 84
ESCITALOPRAM OXALATE 113 104 51 51
ATENOLOL-CHLORTHALIDONE 109 74 52 147
HYDROCODONE BIT-IBUPROFEN 105 75 S3 53 374
SPIRONOLACTONE 105 63 53 85
PLAVIX 104 79 55 42
DILTIAZEM ER 102 79 56 129
SUCRALFATE 101 73 57 158
METOCLOPRAMIDE HCL 98 90 58 125
QUETIAPINE FUMARATE 97 68 59 73
CELEBREX 96 74 60 91
ADVAIR DISKUS 96 83 60 52
FAMOTIDINE 95 62 62 90
LISINOPRIL-HYDROCHLOROTHIAZIDE 95 72 62 21
LACTULOSE 92 63 64 112
DIOVAN 86 77 65 33
AMOX TR-POTASSIUM CLAVULANATE 85 49 66 132
SULFAMETHOXAZOLE-TRIMETHOPRIM 83 62 67 76
CITALOPRAM HBR 82 41 68 20
GLYBURIDE MICRONIZED 78 78 R 69 203
TIZANIDINE HCL 78 50 69 106
CYCLOBENZAPRINE HCL 75 13 R 71 64
JANUVIA 75 37 71 59
VESICARE 74 60 73 188
VERAPAMIL ER 73 46 74 87
PROMETHAZINE HCL 71 11 R 75 104
IRBESARTAN 69 64 76 332
AZITHROMYCIN 69 57 76 37
LOSARTAN-HYDROCHLOROTHIAZIDE 68 60 78 57
MEGESTROL ACETATE 66 63 R 79 92
DOXYCYCLINE HYCLATE 65 44 80 89
NITROSTAT 65 37 80 279
BENICAR 65 51 80 180
PHENYTOIN SODIUM EXTENDED 64 25 83 111
FINASTERIDE 64 49 83 108
INSULIN SYRINGE 63 37 85 99
COMBIVENT 62 55 86 144
DIOVAN HCT 58 52 87 48
CLINDAMYCIN HCL 57 28 88 276
EXELON 57 57 88 113
FLUTICASONE PROPIONATE 56 32 90 39
LANSOPRAZOLE 56 39 90 171
DILTIAZEM 24HR ER 56 45 90 149
OXYBUTYNIN CHLORIDE 54 42 93 139
AMIODARONE HCL 54 54 93 206
NIFEDIPINE ER 54 42 93 75
SEROQUEL 53 32 96 167
IBANDRONATE SODIUM 53 52 96 338
LEVETIRACETAM 52 23 98 137
IPRATROPIUM-ALBUTEROL 52 47 98 193
ROPINIROLE HCL 52 44 98 93
MIRTAZAPINE 50 29 101 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 18, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.